The Sienna Team

Nader Naini
Advisory Board Member
General Partner Frazier Healthcare

Mr. Naini began his professional career as a researcher at the Wistar Institute, and he subsequently worked at Goldman Sachs & Co. Mr. Naini joined Frazier Healthcare shortly after inception in 1991 and has been a General Partner and served on the firm's management committee since 1995.

Mr. Naini leads the firm's growth equity investment practice and continues to selectively invest in late stage biopharma and medical device companies. Historically, he has been involved with several of the firm's biopharma investments, including CV Therapeutics (NASDAQ: CVTX), Tularik (NASDAQ: TLRK) and ZymoGenetics (NASDAQ: ZGEN). More recently, Mr. Naini was the chairman of the board of Aspen Education Group (Aspeneducation.com) which was sold in November 2006 to Bain Capital sponsored CRC Corporation. He currently serves on the boards of Bariatric Partners Inc., CHG Healthcare Services, Elder Health, La Jolla Pharmaceuticals (NASDAQ: LJPC), Priority Solutions, ppoNEXT, PENtech Infusions, Inc., and ZONARE Medical Systems, Inc.

Mr. Naini received his M.B.A. from the Leonard N. Stern School of Business at New York University and a B.A. in molecular biology from the University of Pennsylvania.